Predictive value for axillary lymph node metastases in early breast cancer: Based on contrast-enhanced ultrasound characteristics of the primary lesion and sentinel lymph node
Restricted accessResearch articleFirst published online April 10, 2024
Predictive value for axillary lymph node metastases in early breast cancer: Based on contrast-enhanced ultrasound characteristics of the primary lesion and sentinel lymph node
To evaluate the value of contrast-enhanced ultrasound (CEUS) characteristics based on primary lesion combined with lymphatic contrast-enhanced ultrasound (LCEUS) patterns of SLN in predicting axillary lymph node metastasis (ALNM) with T1-2N0 breast cancer.
METHODS:
A retrospective study was conducted in 118 patients with clinically confirmed T1-2N0 breast cancer. Conventional ultrasound (CUS) and CEUS characteristics of the primary lesion and enhancement patterns of SLN were recorded. The risk factors associated with ALNM were selected by univariate and binary logistic regression analysis, and the receiver operating characteristic (ROC) curve was drawn for the evaluation of predictive ALNM metastasis performance.
RESULTS:
Univariate analysis showed that age, HER-2 status, tumor size, nutrient vessels, extended range of enhancement lesion, and the enhancement patterns of SLN were significant predictive features of ALNM. Further binary logistic regression analysis indicated that the extended range of enhancement lesion (p < 0.001) and the enhancement patterns of SLN (p < 0.001) were independent risk factors for ALNM. ROC analysis showed that the AUC of the combination of these two indicators for predicting ALNM was 0.931 (95% CI: 0.887–0.976, sensitivity: 75.0%, specificity: 99.8%).
CONCLUSION:
The CEUS characteristics of primary lesion combined with enhancement patterns of SLN are highly valuable in predicting ALNM and can guide clinical axillary surgery decision-making in early breast cancer.
SiegelRL, MillerKD, FuchsHEet al.
Cancer Statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
2.
SunJ, MathiasBJ, LarongaCet al.
Impact of Axillary Dissection Among Patients With Sentinel Node-Positive Breast Cancer Undergoing Mastectomy. J Natl Compr Canc Netw. 2021;19:40–7.
3.
GradisharWJ, MoranMS, AbrahamJet al.
NCCN Guidelines® Insights: Breast Cancer, Version 4. J Natl Compr Canc Netw. 2021;19:484–93.
4.
NoguchiM, InokuchiM, NoguchiMet al.
Axillary surgery for breast cancer: past, present, and future. Breast Cancer. 2021;28:9–15.
5.
LymanGH, GiulianoAE, SomerfieldMRet al.
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.
6.
FongW, TanL, TanCet al.
Predicting the risk of axillary lymph node metastasis in early breast cancer patients based on ultrasonographic-clinicopathologic features and the use of nomograms: a prospective single-center observational study. Eur Radiol. 2022;32:8200–12.
7.
MiaoH, ZhongJ, XingXet al.
A nomogram based on the risk factors of cervical lymph node metastasis in papillary thyroid carcinoma coexistent with Hashimoto’s thyroiditis. Clin Hemorheol Microcirc. 2023.
8.
ParkVY, KimEK, MoonHJet al.
Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery. Am J Surg. 2018;216:969–73.
9.
ZhangG, ShiY, YinPet al.
A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP. Front Oncol. 2022;12:944569.
10.
BaiX, WangY, SongRet al.
Ultrasound and clinicopathological characteristics of breast cancer for predicting axillary lymph node metastasis. Clin Hemorheol Microcirc. 2023.
11.
TanakaT, KamataM, FukayaSet al.
Usefulness of real-time elastography for diagnosing lymph node metastasis of skin cancer: does elastography potentially eliminate the need for sentinel lymph node biopsy in squamous cell carcinoma?J Eur Acad Dermatol Venereol. 2020;34:754–61.
12.
ZhongL, XieJ, ShiLet al.
Nomogram based on preoperative conventional ultrasound and shear wave velocity for predicting central lymph node metastasis in papillary thyroid carcinoma. Clin Hemorheol Microcirc.. 2023;83:129–36.
13.
DuanY, ZhuY, NieFet al.
Predictive value of combining clinicopathological, multimodal ultrasonic characteristics in axillary lymph nodal metastasis burden of patients with cT1-2N0 breast cancer. Clin Hemorheol Microcirc. 2022;81:255–69.
14.
HuQ, WangXY, ZhuSYet al.
Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions. Acta Radiol. 2015;56:25–33.
15.
XiangLH, YaoMH, XuGet al.
Diagnostic value of contrast-enhanced ultrasound and shear-wave elastography for breast lesions of sub-centimeter. Clin Hemorheol Microcirc. 2017;67:69–80.
16.
GongX, LiQ, GuLet al.
Conventional ultrasound and contrast-enhanced ultrasound radiomics in breast cancer and molecular subtype diagnosis. Front Oncol. 2023;13:1158736.
17.
MarinoMA, AvendanoD, ZapataPet al.
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools. Oncologist. 2020;25:e231–e42.
18.
NieblingMG, PleijhuisRG, BastiaannetEet al.
A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016;42:466–73.
19.
McMastersKM, WongSL, MartinRC2ndet al.
Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–87.
20.
CooperKL, HarnanS, MengYet al.
Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2011;37:187–98.
21.
CuiQ, DaiL, LiJet al.
Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis. World J Surg Oncol. 2020;18:112.
22.
ZhaoJ, ZhangJ, ZhuQLet al.
The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study. Eur Radiol. 2018;28:1654–61.
23.
ZhuY, JiaY, PangWet al.
Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer. Quant Imaging Med Surg. 2023;13:160–70.
24.
NiuZ, XiaoM, MaLet al.
The value of contrast-enhanced ultrasound enhancement patterns for the diagnosis of sentinel lymph node status in breast cancer: systematic review and meta-analysis. Quant Imaging Med Surg. 2022;12:936–48.
25.
van NijnattenTJA, JochelsonMS, LobbesMBIAxillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality. Eur J Radiol. 2022;152:110334.
26.
ChoiHY, ParkM, SeoMet al.
Preoperative Axillary Lymph Node Evaluation in Breast Cancer: Current Issues and Literature Review. Ultrasound Q. 2017;33:6–14.
27.
BabanCK, DevaneL, GeraghtyJChange of paradigm in treating elderly with breast cancer: are we undertreating elderly patients?Ir J Med Sci. 2019;188:379–88.
28.
NgaiV, TaiJCJ, TajSet al.
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis. Breast Cancer Res Treat. 2022;195:161–69.
29.
ZhuY, LvW, WuHet al.
A preoperative nomogram for predicting the risk of sentinel lymph node metastasis in patients with T1-2N0 breast cancer. Jpn J Radiol. 2022;40:595–606.
30.
BaeMS, ShinSU, SongSEet al.
Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1-T2N0 breast cancer. Acta Radiol. 2018;59:402–8.
31.
Khosravi ShahiP, Soria LovelleA, Pérez MangaGTumoral angiogenesis and breast cancer. Clin Transl Oncol. 2009;11:138–42.
32.
LiuZ, LiCCorrelation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma. Clin Hemorheol Microcirc. 2022;82:361–70.
33.
CarmelietP, JainRKAngiogenesis in cancer and other diseases. Nature. 2000;407:249–57.
34.
WiesingerI, JungF, JungEMContrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox®. Clin Hemorheol Microcirc. 2021;78:29–40.
35.
Márquez-GarbánDC, Gorrín-RivasM, ChenHWet al.
Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression. Cancer Lett. 2019;449:66–75.
36.
GiulianoAE, DalePS, TurnerRRet al.
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394–9; discussion 99-401.
37.
MarrazzoA, PalumboVD, MarrazzoEet al.
Localization of sentinel lymph node in breast cancer. A prospective study. Int J Surg. 2014;12Suppl 1:S162–4.
38.
NiuZ, GaoY, XiaoMet al.
Contrast-enhanced lymphatic US can improve the preoperative diagnostic performance for sentinel lymph nodes in early breast cancer. Eur Radiol. 2023;33:1593–602.
39.
LiJ, LuM, ChengXet al.
How Pre-operative Sentinel Lymph Node Contrast-Enhanced Ultrasound Helps Intra-operative Sentinel Lymph Node Biopsy in Breast Cancer: Initial Experience. Ultrasound Med Biol. 2019;45:1865–73.
40.
LiuYB, XiaM, LiYJet al.
Contrast-Enhanced Ultrasound in Locating Axillary Sentinel Lymph Nodes in Patients with Breast Cancer: A Prospective Study. Ultrasound Med Biol. 2021;47:1475–83.
41.
MacdonaldAJ, ArkillKP, TaborGRet al.
Modeling flow in collecting lymphatic vessels: one-dimensional flow through a series of contractile elements. Am J Physiol Heart Circ Physiol. 2008;295:H305–13.
42.
LiL, MoriS, KodamaMet al.
Enhanced sonographic imaging to diagnose lymph node metastasis: importance of blood vessel volume and density. Cancer Res. 2013;73:2082–92.
43.
SeverAR, MillsP, JonesSEet al.
Sentinel node identification using microbubbles and contrast-enhanced ultrasonography. Clin Radiol. 2012;67:687–94.
HaoY, SunY, LeiYet al.
Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer. Eur Radiol. 2021;31:5894–901.
